Literature DB >> 19946579

De Toni-Debré-Fanconi syndrome in a patient with Kearns-Sayre syndrome: a case report.

Cristina Maria Mihai1, Doina Catrinoiu, Marius Toringhibel, Ramona Mihaela Stoicescu, Anca Hancu.   

Abstract

INTRODUCTION: Kearns-Sayre syndrome is a mitochondrial myopathy that demonstrates chronic progressive ophthalmoplegia with onset before the age of 20 and pigmentary degeneration of the retina. CASE
PRESENTATION: We report the case of an 18-year-old Romanian man with short stature, external ophthalmoplegia, palpebral ptosis, myopathy, sensorineural hearing impairment, cerebellar ataxia, cardiac conduction defect, diabetes mellitus, hypoparathyroidism and hyperaldosteronism. The patient's evolution showed progressive insufficiency of the renal tubule: hyperphosphaturia, hyperaminoaciduria and, later, glucosuria (de Toni-Debré-Fanconi syndrome), a syndrome, to date, rarely diagnosed in association with complete Kearns-Sayre syndrome. The final diagnosis was delayed for several years and was only established when he developed diabetes mellitus. Southern blot analysis and polymerase chain reaction amplification revealed the presence of a deletion in the mitochondrial DNA.
CONCLUSION: DESPITE THE RARITY OF THIS SYNDROME, THE DIAGNOSIS WAS EASILY MADE DUE TO THE PRESENCE OF THE CLASSIC TRIAD: external ophthalmoplegia, pigmentary retinopathy and onset in a patient younger than 20 years old. In our opinion, a search for Kearns-Sayre syndrome in all patients with de Toni-Debré-Fanconi syndrome is a valuable medical routine.

Entities:  

Year:  2009        PMID: 19946579      PMCID: PMC2783042          DOI: 10.1186/1752-1947-3-101

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  19 in total

1.  Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases.

Authors:  T P KEARNS; G P SAYRE
Journal:  AMA Arch Ophthalmol       Date:  1958-08

2.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

3.  Therapeutic approach in a case of Pearson's syndrome.

Authors:  M Zaffanello; G Zamboni
Journal:  Minerva Pediatr       Date:  2005-06       Impact factor: 1.312

4.  Kearns-Sayre syndrome associated with de Toni-Debré-Fanconi syndrome due to cytochrome-c-oxidase (COX) deficiency.

Authors:  A Berio; A Piazzi
Journal:  Panminerva Med       Date:  2001-09       Impact factor: 5.197

5.  [Progressive ptosis in children as a presenting sign of Kearns-Sayre syndrome].

Authors:  R Gal; E Lahat
Journal:  Harefuah       Date:  2000-01-16

6.  Kearns-Sayre syndrome with a novel mitochondrial DNA deletion.

Authors:  J Marin-Garcia; M J Goldenthal; H B Sarnat
Journal:  J Child Neurol       Date:  2000-08       Impact factor: 1.987

7.  Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis.

Authors:  H Mochizuki; K Joh; H Kawame; A Imadachi; H Nozaki; T Ohashi; N Usui; Y Eto; Y Kanetsuna; S Aizawa
Journal:  Clin Nephrol       Date:  1996-11       Impact factor: 0.975

8.  Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

Authors:  J M Shoffner; M T Lott; A S Voljavec; S A Soueidan; D A Costigan; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Patient with Fanconi Syndrome (FS) and retinitis pigmentosa (RP) caused by a deletion and duplication of mitochondrial DNA (mtDNA).

Authors:  E M Pitchon; F Cachat; S Jacquemont; C Hinard; F-X Borruat; D F Schorderet; M A Morris; F L Munier
Journal:  Klin Monbl Augenheilkd       Date:  2007-04       Impact factor: 0.700

10.  Treatment of Kearns-Sayre syndrome with coenzyme Q10.

Authors:  S Ogasahara; Y Nishikawa; S Yorifuji; F Soga; Y Nakamura; M Takahashi; S Hashimoto; N Kono; S Tarui
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

View more
  4 in total

1.  A rare case report of simultaneous presentation of myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome.

Authors:  Meropi Tzoufi; Alexandros Makis; Nikolaos Chaliasos; Iliada Nakou; Ekaterini Siomou; Agathoklis Tsatsoulis; Anastasia Zikou; Maria Argyropoulou; Jean Paul Bonnefont; Antigone Siamopoulou
Journal:  Eur J Pediatr       Date:  2012-08-09       Impact factor: 3.183

2.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

3.  Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome (PMPS): Two case reports in Barranquilla, Colombia.

Authors:  Vanessa Sabella-Jiménez; Carlos Otero-Herrera; Carlos Silvera-Redondo; Pilar Garavito-Galofre
Journal:  Mol Genet Genomic Med       Date:  2020-10-08       Impact factor: 2.183

Review 4.  Mitochondrial DNA mutations in renal disease: an overview.

Authors:  Larissa P Govers; Hakan R Toka; Ali Hariri; Stephen B Walsh; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2020-01-10       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.